Key Variables Ascertainment and Validation in RW Setting

Sai Dharmarajan and Tae Hyun Jung ()
Additional contact information
Sai Dharmarajan: Center for Drug Evaluation and Research, Food and Drug Administration, Division of Biometrics VII, Office of Biostatistics, Office of Translational Sciences
Tae Hyun Jung: Center for Drug Evaluation and Research, Food and Drug Administration, Division of Biometrics VII, Office of Biostatistics, Office of Translational Sciences

A chapter in Real-World Evidence in Medical Product Development, 2023, pp 63-78 from Springer

Abstract: Abstract Ascertainment of key variables is a major component in the FDA Real-World Evidence (RWE) framework (FDA. Framework for FDA’s real-world evidence program. https://www.fda.gov/media/120060/download , 2018). Key variables are those that define a key patient characteristic necessary to identify the study population of interest, the treatment/exposure, the outcome, or a key confounder whose effect must be adjusted for. With Real-World Data (RWD), often (1) exposure, outcomes, and key confounders cannot be measured directly, requiring the use of proxies and linkage to external data sources to determine these; (2) no single variable can measure a desired characteristic, requiring characteristics be ascertained through computations or combinations of many data fields using a manually pre-defined rule or computer-generated algorithms; (3) information on the characteristic of interest is contained within another data element such as text field, requiring natural language processing techniques such as information extraction be applied; (4) misclassification is a concern, requiring validation studies. This chapter will cover the above topics and walk through an example study for which the ascertainment of key variables was found to be acceptable from a regulatory standpoint.

Keywords: Ascertainment; Identification; Phenotyping; Validation; Misclassification; Rule-based; Machine learning-based phenotyping (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-26328-6_5

Ordering information: This item can be ordered from
http://www.springer.com/9783031263286

DOI: 10.1007/978-3-031-26328-6_5

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().